<DOC>
	<DOCNO>NCT01482286</DOCNO>
	<brief_summary>Polycystic ovary syndrome ( PCOS ) common reproductive disorder woman reproductive age despite decade research etiology disorder know . The characteristic hyperandrogenism anovulation associate abnormal neuroendocrine function insulin resistance . Obesity common correlate phenotype Polycystic ovary syndrome weight gain worsens reproductive metabolic complication . Currently evidence-based treatment plan infertility Polycystic ovary syndrome ; yet weight loss dietary restriction regular exercise strongly advocate . Weight loss increase insulin sensitivity appear drive improvement reproductive outcome woman Polycystic ovary syndrome ; however , mechanism connect change reproductive axis fully understood .</brief_summary>
	<brief_title>Effect Weight Insulin Sensitivity Reproductive Function PCOS</brief_title>
	<detailed_description>The goal study determine ( use dietary restriction , exercise training , metformin treatment ) , effect weight loss and/or improve insulin sensitivity reproductive function ( neuroendocrine ovarian ) obese woman Polycystic ovary syndrome .</detailed_description>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>20 40 year , inclusive Body mass index ≥ 25 kg/m2 History irregular menstrual cycle ( few 6 cycle past year ) Clinical and/or biochemical androgen excess ( Free androgen index &gt; 3.85 and/or hirsuitism rating ≥8 ) Anovulatory menstrual cycle ( determined screening ) Ovulatory menstrual cycle ( determine screen luteal phase serum progesterone &gt; 3ng/mL ) History clinical appearance cardiovascular disease , diabetes ( Type 1 Type 2 ) significant reproductive , metabolic , hematologic , pulmonary , gastrointestinal , neurologic , immune , hepatic , renal , urologic disorder , cancer . Hemoglobin , hematocrit , red blood cell count , iron level lower limit normal screen visit confirm test repeat within two week Regular use medication weight control , glucose intolerance , thyroid disease Use hormonal contraception contain medroxyprogesterone acetate ( A 3 month washout period permit oral , vaginal transdermal contraceptive ) . Psychiatric Behavioral Exclusion Criteria Smoking History drug alcohol abuse ( 14 drink week allow ) within past two year History presence eat disorder determine Interview Diagnosis Eating Disorders ( IDEDIV ) Beck Depression Index ( BDI ) score ≥15 screening baseline Other Exclusion Criteria Individuals lose 5kg ( 11lbs ) past 6 month Individuals pregnant breastfeeding become pregnant study Individuals engage regular program physical fitness involve heavy physical activity ( e.g. , jog rid fast bicycle 30 minute ) least five time per week past year Individuals metallic object body Individuals donate blood within 30 day prior date randomization Individuals unwilling assign random either one intervention group Unwilling unable adhere rigor data collection ( determine food activity diaries screening , see ) clinical evaluation schedule entire 24 week intervention period Individuals plan move area within next 12 month plan study area 4 week next 12 month Individuals reside far Pennington</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Exercise</keyword>
	<keyword>Diet</keyword>
	<keyword>Insulin resistance</keyword>
	<keyword>Weight</keyword>
</DOC>